BLUA vs. ALUR, BWAY, KRMD, STIM, TELA, NVNO, SEPA, MGRM, SRTS, and PDEX
Should you be buying BlueRiver Acquisition stock or one of its competitors? The main competitors of BlueRiver Acquisition include Allurion Technologies (ALUR), BrainsWay (BWAY), KORU Medical Systems (KRMD), Neuronetics (STIM), TELA Bio (TELA), enVVeno Medical (NVNO), SEP Acquisition (SEPA), Monogram Orthopaedics (MGRM), Sensus Healthcare (SRTS), and Pro-Dex (PDEX). These companies are all part of the "surgical & medical instruments" industry.
Allurion Technologies (NYSE:ALUR) and BlueRiver Acquisition (NYSE:BLUA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.
BlueRiver Acquisition has lower revenue, but higher earnings than Allurion Technologies.
Allurion Technologies received 3 more outperform votes than BlueRiver Acquisition when rated by MarketBeat users.
21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 22.3% of BlueRiver Acquisition shares are held by institutional investors. 20.0% of Allurion Technologies shares are held by insiders. Comparatively, 79.0% of BlueRiver Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Allurion Technologies currently has a consensus target price of $5.00, indicating a potential upside of 164.55%. Given BlueRiver Acquisition's higher probable upside, equities research analysts clearly believe Allurion Technologies is more favorable than BlueRiver Acquisition.
In the previous week, Allurion Technologies had 12 more articles in the media than BlueRiver Acquisition. MarketBeat recorded 13 mentions for Allurion Technologies and 1 mentions for BlueRiver Acquisition. BlueRiver Acquisition's average media sentiment score of 0.42 beat Allurion Technologies' score of 0.33 indicating that Allurion Technologies is being referred to more favorably in the media.
Summary
Allurion Technologies beats BlueRiver Acquisition on 6 of the 10 factors compared between the two stocks.
Get BlueRiver Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for BLUA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BLUA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BlueRiver Acquisition Competitors List
Related Companies and Tools
